CSI Market
Sign In | Register

Pra Health Sciences Inc (PRAH) Annual Cash Flow Statement

Annual · GAAP · USD millions
Access PRAH quarterly Cash Flow →
Quarterly cash flow trends provide additional context on Pra Health Sciences Inc's liquidity and ability to support ongoing operations and capital needs.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Dec 31 2020)
12 Months 		(Dec 31 2019) (Dec 31 2018) (Dec 31 2017) (Dec 31 2016)
Operating Activities
Income197.04
Depreciation & amortization131.63
Amortization of Other Assets1.69
Increase (Decrease) in Deferred Revenue0.00
Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability-44.50
Provision For Loan Losses Expensed0.00
Inventories Decrease /-Increase0.00
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property0.32
Share-based Compensation0.00
Income (Loss) from Equity Method Investments0.00
Foreign Currency Transaction Gain (Loss), Unrealized31.31
Noncash Gains Losses On Modification Or Extinguishment Of Debt-
Increase Decrease In Accounts Receivable And Unbilled Services-172.22
Share Based Compensation Excluding Non Cash Transaction Costs69.41
Share Based Compensation Non Cash Transaction Costs-
Increase Decrease In Contract With Customer Liability214.70
Increase Decrease In Accounts Receivable Unbilled Receivables And Advance Billings Net-
Income taxes-20.29
Unrealized Gain (Loss) on Derivatives0.00
Increase (Decrease) in Income Taxes-0.06
Increase (Decrease) in Accounts Payable and Other Operating Liabilities11.09
Accrued Expense0.00
Deferred Revenue and Customer Advances and Deposits0.00
Prepaid Expense and Other Assets0.00
Other Working Capital0.00
Other Noncash Income (Expense)8.95
Other net0.00
Payments for (Proceeds from) Other Operating Activities-1.88
Discontinued operations0.00
Net Cash flow from Operating Activities427.18
Investing Activities
Capital Expenditures-66.81
Sale of Capital Items0.03
Proceeds from Sale and Maturity of Marketable Securities0.00
Short-term Investments Acq.0.00
Payments for (Proceeds from) Derivative Instrument, Investing Activities-8.30
Escrow Deposit Disbursements Related To Acquisition-
Derivative Cash Paid On Hedge-
Derivative Cash Paid On Hedge Interest-
Proceeds From Previous Acquisition Two-
Payments To Acquire Business Six Net Of Cash Acquired-
Payment For Contingent Consideration Liability Investing Activities-
Paymentsto Acquire Business Five Net of Cash Acquired-
Statement Line Items-
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Payments for (Proceeds from) Other Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Payments to Acquire Businesses, Net of Cash Acquired-158.82
Interest in Subsidiaries and Affiliates0.00
Sale of businesses0.00
Accounts payable0.00
Repayments of Accounts Receivable Securitization0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities-233.90
Financing Activities
Short-term debt Net2.50
Other borrowing transactions41.58
Long-term debt - borrowings0.00
Long-term debt - repayments-25.00
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock58.35
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net0.00
Payments Of Acquisition Related Contingent Consideration-
Payments Of Debt Extinguishment And Prepayment Costs-
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities77.43
Effect of exchange rate on cash flow-0.67
Discontinued operations0.00
Free Cash Flow360.40
Total Cash Flow270.03
4 historic quarters locked

Sign in to unlock the full Pra Health Sciences Inc cash flow history.

Sign In Create Free Account

About PRAH Annual Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-K filings and normalized by CSIMarket.

Source & verification

  • Form: 10-K
  • Filed with the SEC: n/a

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.

Figures are derived from filed reports and may be restated. Historical data is subject to revision.

Untitled Document 





                    


    



  Get the full CSIMarket dataset:
  Subscribe
  API
  License